Valter Gattei

Best Publications

• Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation

  Giulia Fabbri;Silvia Rasi;Davide Rossi;Vladimir A. Trifonov

  782
  Citations

• Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia

  Davide Rossi;Silvia Rasi;Valeria Spina;Alessio Bruscaggin

  601
  Citations

• Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia

  Davide Rossi;Silvia Rasi;Giulia Fabbri;Valeria Spina

  564
  Citations

• Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness.

  Davide Rossi;Alessio Bruscaggin;Valeria Spina;Silvia Rasi

  485
  Citations

• The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation

  Davide Rossi;Valeria Spina;Clara Deambrogi;Silvia Rasi

  441
  Citations

• The coding genome of splenic marginal zone lymphoma: Activation of NOTCH2 and other pathways regulating marginal zone development

  Davide Rossi;Vladimir Trifonov;Marco Fangazio;Alessio Bruscaggin

  439
  Citations

• Clinical impact of small TP53 mutated subclones in chronic lymphocytic leukemia

  Davide Rossi;Hossein Khiabanian;Valeria Spina;Carmela Ciardullo

  415
  Citations

• The prognostic value of TP53 mutations in chronic lymphocytic leukemia is independent of Del17p13: implications for overall survival and chemorefractoriness.

  Davide Rossi;Michaela Cerri;Clara Deambrogi;Elisa Sozzi

  415
  Citations

• Disruption of BIRC3 associates with Fludarabine Chemorefractoriness in TP53 Wild Type Chronic Lymphocytic Leukemia

  Davide Rossi;Marco Fangazio;Silvia Rasi;Tiziana Vaisitti

  400
  Citations

• Relevance of CD49d protein expression as overall survival and progressive disease prognosticator in chronic lymphocytic leukemia

  Valter Gattei;Pietro Bulian;Maria Ilaria Del Principe;Antonella Zucchetto

  328
  Citations

• Biological and clinical risk factors of chronic lymphocytic leukaemia transformation to Richter syndrome.

  Davide Rossi;Michaela Cerri;Daniela Capello;Clara Deambrogi

  296
  Citations

• Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome

  Ekaterina Chigrinova;Andrea Rinaldi;Ivo Kwee;Ivo Kwee;Davide Rossi

  293
  Citations

• Stereotyped B-Cell Receptor Is an Independent Risk Factor of Chronic Lymphocytic Leukemia Transformation to Richter Syndrome

  Davide Rossi;Valeria Spina;Michaela Cerri;Silvia Rasi

  263
  Citations

• Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia.

  Davide Rossi;Lodovico Terzi-di-Bergamo;Lorenzo De Paoli;Michaela Cerri

  257
  Citations

• CD49d is the strongest flow cytometry-based predictor of overall survival in chronic lymphocytic leukemia.

  Pietro Bulian;Tait D. Shanafelt;Chris Fegan;Antonella Zucchetto

  252
  Citations

• Clinical significance of ZAP-70 protein expression in B-cell chronic lymphocytic leukemia

  Maria Ilaria Del Principe;Giovanni Del Poeta;Francesco Buccisano;Luca Maurillo

  236
  Citations

• Expression of functional CD40 antigen on Reed-Sternberg cells and Hodgkin's disease cell lines.

  A Carbone;A Gloghini;V Gattei;D Aldinucci

  232
  Citations

• Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome

  Andrea Rinaldi;Michael Mian;Ekaterina Chigrinova;Luca Arcaini

  213
  Citations

• The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors.

  Davide Rossi;Elisa Sozzi;Alessia Puma;Lorenzo De Paoli

  191
  Citations

• Human eosinophils express functional CD30 ligand and stimulate proliferation of a Hodgkin's disease cell line

  Antonio Pinto;Donatella Aldinucci;Annunziata Gloghini;Vittorina Zagonel

  187
  Citations